Incyte Corp (NASDAQ: INCY)’s stock price has gone rise by 5.12 in comparison to its previous close of 67.75, however, the company has experienced a 1.90% increase in its stock price over the last five trading days. businesswire.com reported 2025-06-15 that VENLO, Netherlands & WILMINGTON, Del.–(BUSINESS WIRE)—- $QGEN #QIAGEN–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Incyte (Nasdaq: INCY) today announced a new global collaboration to develop a novel diagnostic panel to support Incyte’s extensive portfolio of investigational therapies for patients with myeloproliferative neoplasms (MPNs), a group of rare blood cancers, including Incyte’s monoclonal antibody INCA033989, targeting mutant calreticulin (mutCALR), which is being developed in myelofi.
Is It Worth Investing in Incyte Corp (NASDAQ: INCY) Right Now?
Incyte Corp (NASDAQ: INCY) has a higher price-to-earnings ratio of 220.36x compared to its average ratio, The 36-month beta value for INCY is at 0.68. Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 2 rating it as “overweight,” 16 as “hold,” and 0 as “sell.”
The public float for INCY is 190.87M, and currently, shorts hold a 4.42% of that float. The average trading volume for INCY on June 17, 2025 was 2.12M shares.
INCY’s Market Performance
INCY’s stock has seen a 1.90% increase for the week, with a 13.48% rise in the past month and a 14.85% gain in the past quarter. The volatility ratio for the week is 3.28%, and the volatility levels for the past 30 days are at 1.73% for Incyte Corp The simple moving average for the last 20 days is 6.55% for INCY’s stock, with a simple moving average of 5.19% for the last 200 days.
Analysts’ Opinion of INCY
Many brokerage firms have already submitted their reports for INCY stocks, with Stifel repeating the rating for INCY by listing it as a “Buy.” The predicted price for INCY in the upcoming period, according to Stifel is $107 based on the research report published on June 16, 2025 of the current year 2025.
INCY Trading at 13.93% from the 50-Day Moving Average
After a stumble in the market that brought INCY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.16% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INCY starting from Denton Sheila A., who sale 1,795 shares at the price of $68.00 back on Jun 03 ’25. After this action, Denton Sheila A. now owns 26,504 shares of Incyte Corp, valued at $122,060 using the latest closing price.
SHEILA DENTON, the Officer of Incyte Corp, proposed sale 1,795 shares at $68.00 during a trade that took place back on Jun 03 ’25, which means that SHEILA DENTON is holding shares at $122,060 based on the most recent closing price.
Stock Fundamentals for INCY
Current profitability levels for the company are sitting at:
- 0.04 for the present operating margin
- 0.92 for the gross margin
The net margin for Incyte Corp stands at 0.0. The total capital return value is set at 0.04. Equity return is now at value 0.47, with 0.33 for asset returns.
Based on Incyte Corp (INCY), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 8.87. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 69.93.
Currently, EBITDA for the company is 408.16 million with net debt to EBITDA at -4.67. When we switch over and look at the enterprise to sales, we see a ratio of 2.69. The receivables turnover for the company is 5.36for trailing twelve months and the total asset turnover is 0.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.04.
Conclusion
In conclusion, Incyte Corp (INCY) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
